Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1574 participants.

Also called NCT07601763

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,574 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07601763
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07601763. Randomized; single masking; primary purpose treatment. Start 2025-04-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
Acronym
POWER-AF
Condition
Atrial Fibrillation (AF)
Condition
Atrial Fibrillation Ablation
Condition
Atrial Fibrillation Recurrent
Condition
Pulsed Field Ablation
Condition
Radiofrequency Catheter Ablation
Intervention (Procedure)
Pulsed field ablation
Intervention (Procedure)
Radiofrequency ablation alone
Intervention (Device)
Pulsed field ablation system
Lead sponsor
China National Center for Cardiovascular Diseases (class: other government)

Record details

Record id
cardio:ct-nct07601763
Content hash
0cede7f284cc13158c64a40d07c21188681c67987ffaecce0f96697993081c06